The Chinese economy is set to overtake the U.S. faster than previously anticipated after weathering the coronavirus pandemic better than the West, according to the Centre for Economics and Business Research.
The world’s biggest and second-biggest economies are on course to trade places in dollar terms in 2028, five years earlier than expected a year ago, it said on Saturday.
In its World Economic League Table, the consultancy also calculated that China could become a high-income economy as soon as 2023. Further cementing Asia’s growing might, India is set to move up the rankings to become the No. 3 economy at the end of the decade.
Chinese President Xi Jinping said last month it was “entirely possible” for his economy to double in size by 2035 under his government’s new Five-Year Plan, which aims to achieve “modern socialism” in 15 years.
China was the first economy to suffer a pandemic blow, but has recovered swiftly, according to government data. That should prompt Western economies to pay much more attention to what is happening in Asia, according to the report.
“Typically, we compare ourselves with other Western economies and miss out on what often is best practice, especially in the rapidly growing economies in Asia,” it said.
More must-read stories from Fortune:
- Everything to know about the stimulus deal—including $600 checks and $300 unemployment benefits
- Biden wants to change how credit scores work in America
- COVID vaccine recipients may still be infectious. When will we know for sure?
- How Hawaii’s COVID-19 testing program could serve as the blueprint for a broader reopening of international travel
- Trump pardons: 7 high profile people who may get one
It’s always Black Women’s Equal Pay day
The fatal shooting of a 13-year-old boy by the Chicago police spark protests, a new documentary sheds light on six survivors of the Titanic, and the Methodist church welcomes its first drag queen minister-candidate. Read More
Famed short seller predicts SPAC boom crash
“If there ever was a good SPAC deal, it was probably about 300 SPACs ago.” Read More
The pandemic is hurting female scientists—that’s bad news for all of us
Since the onset of the pandemic, women have published fewer papers, led fewer clinical trials, and gotten less recognition for their expertise. Read More